[HTML][HTML] Tuberculosis–cancer parallels in immune response regulation

TE Bickett, SD Karam - International Journal of Molecular Sciences, 2020 - mdpi.com
Mycobacterium tuberculosis and cancer are two diseases with proclivity for the development
of resistance to the host immune system. Mechanisms behind resistance can be host …

The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer

D Bhattacharya, K Sakhare, KP Narayan… - … , Biology and Medicine, 2021 - Elsevier
OSCC (oral squamous cell carcinoma) is currently one of the most formidable cancers
plagued by challenges like low overall survivability, lymph node associated metastasis, drug …

EGFR overexpression and macrophage infiltration correlate with poorer prognosis in HPV‐negative oropharyngeal cancer via STAT6 signaling

HP Lee, CJ Li, CC Lee - Head & Neck, 2024 - Wiley Online Library
Background The prevalence of HPV‐negative oropharyngeal cancer (OPC) is higher in
Asian countries. Patients with HPV‐negative OPC suffer poor outcomes. Multi‐omics …

PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment

Y He, J Xiang, Y Li, W Huang, F Gu, Y Wang… - Cancer …, 2023 - Wiley Online Library
Background As a nucleolar protein associated with ribosome biogenesis in multiple cancer
types, PES1 has been reported to be overexpressed, promoting cancer cell proliferation and …

[HTML][HTML] TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma

Y He, Y Li, J Xiang, X Huang, M Zhao, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Tyrosine kinase 2 (TYK2) is a member of the Janus kinase (JAK) family and is involved in
immune and inflammatory signaling. TYK2 is overexpressed in several types of cancers and …

[HTML][HTML] Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma

E Jumaniyazova, A Lokhonina, D Dzhalilova… - Journal of Personalized …, 2023 - mdpi.com
Head and neck squamous cell cancer (HNSCC) is one of the ten most common malignant
neoplasms, characterized by an aggressive course, high recurrence rate, poor response to …

[HTML][HTML] A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma

R Fang, M Iqbal, L Chen, J Liao, J Luo, F Wei… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC), the most frequent subtype of head and
neck cancer, continues to have a poor prognosis with no improvement. The TNM stage is not …

[HTML][HTML] Prognostic matrisomal gene panel and its association with immune cell infiltration in head and neck carcinomas

Y Belotti, SB Lim, NG Iyer, WT Lim, CT Lim - Cancers, 2021 - mdpi.com
Simple Summary Squamous cell carcinoma of the head and neck (SCCHN) is a
heterogeneous group of tumors arising from squamous cells lining different anatomic sites …

First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer—What Happened?

B Burtness - Journal of Clinical Oncology, 2023 - ascopubs.org
Immune checkpoint inhibition (ICI) with the PD-1 inhibitor pembrolizumab prolongs survival
for patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) in …

[HTML][HTML] Tumor-associated macrophages: Harbingers of aggressiveness in oral squamous cell carcinoma

A Mukherjee, A Spadigam… - Journal of Oral and …, 2021 - journals.lww.com
Background: The significance of the tumor microenvironment (TME) as a modulator of tumor
behavior was acknowledged by Hanahan and Weinberg in 2011 as the emerging hallmarks …